Class I — Serious Health Hazard

Serious health hazard — there is a reasonable probability that use of or exposure to this product will cause serious adverse health consequences or death.

Leccurate SARS-CoV-2 Recalled by LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD Due to Leccurate SARS-CoV-2, Antibody Rapid Test Kit (Colloidal Gold...

Date: April 26, 2021
Company: LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD
Status: Completed
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD directly.

Affected Products

Leccurate SARS-CoV-2, Antibody Rapid Test Kit (Colloidal Gold Immunochromatography), 1 test, IVD. for qualitative detection of IgM and/or IgG antibodies to SARS-CoV-2 in human serum, plasma and venipuncture whole blood for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

Quantity: 8, 419, 545 units in total

Why Was This Recalled?

Leccurate SARS-CoV-2, Antibody Rapid Test Kit (Colloidal Gold Immunochromatography) is not authorized, cleared, or approved for marketing and/or distribution in the U.S.

Where Was This Sold?

This product was distributed to 4 states: FL, GA, IL, NY

Affected (4 states)Not affected

About LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD

LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD has 2 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report